Modified mohs micrographic surgery for periocular melanoma and melanoma in situ: Long-term experience at scripps clinic

Dermatologic Surgery

Volumn 35, Issue 8, 2009, Pages 1263-1270

  Shumaker, Peter R ^a   Kelley, Ben ^a   Swann, Michael H ^a   Greenway, Hubert T ^a  

^a SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARAFFIN;

ADULT; ARTICLE; CANCER SURGERY; CHEMOSURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; MALE; MELANOMA; MORBIDITY; PRIMARY TUMOR; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT CANCER; TREATMENT OUTCOME;

EYE; FACIAL NEOPLASMS; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MOHS SURGERY; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 68749083830     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2009.01222.x     Document Type: Article

References (34)

1. Boulos P, Rubin P. Cutaneous melanomas of the eyelid. Sem Ophthalmol 2006 21 : 195 206.
2. Nijhawan N, Ross MI, Diba R, et al. Experience with sentinel lymph node biopsy for eyelid and conjunctival malignancies at a cancer center. Opthal Plast Reconstr Surg 2004 20 : 291 5.
3. Cohen L. Lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol 1995 33 : 923 40.
4. Chan F, O'Donnell B, Whitehead K, et al. Treatment and outcomes of malignant melanoma of the eyelid. A review of 29 cases in Australia. Ophthalmol 2007 114 : 187 92.
5. Vaziri M, Buffman F, Martinka M, et al. Clinicopathologic features and behavior of cutaneous eyelid melanoma. Ophthalmol 2002 109 : 901 8.
6. Zalaudek I, Horn M, Richtag E, et al. Local recurrence in melanoma in situ: influence of sex, age, site of involvement and therapeutic modalities. Br J Dermatol 2003 148 : 703 8.
7. Dhawan S, Wolf D, Rabinovitz H, Poulos E. Lentigo maligna. The use of rush permanent sections in therapy. Arch Dermatol 1990 126 : 928 30.
8. Bub J, Berg D, Slee A, Odland P. Management of lentigo maligna and lentigo maligna melanoma with staged excision. Arch Dermatol 2004 140 : 552 8.
9. Walling H, Scupham R, Bean A, Ceilley R. Staged excision versus Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol 2007 57 : 659 64.
10. Swetter SM, Boldrick JC, Jung SY, et al. Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990-2000. J Invest Dermatol 2005 125 : 685 91.
11. Weinstock MA, Sober AJ. The risk of progression of lentigo maligna to lentigo maligna melanoma. Br J Dermatol 1987 116 : 303 10.
12. Wayte DM, Helwig EB. Melanotic freckle of Hutchinson. Cancer 1968 21 : 893 911.
13. Grossniklaus HE, McLean IW. Cutaneous melanoma of the eyelid. Clinicopathologic features. Opthalmol 1991 98 : 1867 73.
14. Tahery DP, Goldberg R, Moy RL. Malignant melanoma of the eyelid. J Am Acad Dermatol 1992 27 : 17 21.
15. McKenna JK, Florell SR, Goldman GD, et al. Lentigo maligna/lentigo maligna melanoma: current state of diagnosis and treatment. Dermatol Surg 2006 32 : 493 504.
16. Agarwal-Antal N, Bowen G, Gerwels J. Histologic evaluation of lentigo maligna with permanent sections: implications regarding current guidelines. J Am Acad Dermatol 2002 47 : 743 8.
17. National Institutes of Health Consensus Conference. Diagnosis and treatment of early melanoma. JAMA 1992 268 : 1314 9.
18. Coleman WP, Davis RS, Reed RJ. Treatment of lentigo maligna and lentigo maligna melanoma. J Dermatol Surg Oncol 1980 6 : 476 9.
19. Pitman GH, Kopf AW, Bart RS, et al. Treatment of lentigo maligna and lentigo maligna melanoma. J Dermatol Surg Oncol 1979 9 : 727 37.
20. Osborne JE, Hutchinson PE. A follow-up study to investigate the efficacy of initial treatment of lentigo maligna with surgical excision. Br J Plast Surg 2002 55 : 611 5.
21. Garner A, Koornneef L, Levene A, Collin J. Malignant melanoma of the eyelid skin: histopathology and behavior. Br J Ophthalmol 1985 69 : 180 6.
22. Esmaeli B, Wang B, Deavers M, et al. Prognostic factors for survival in malignant melanoma of the eyelid skin. Ophthalm Plast Reconstr Surg 2000 16 : 250 7.
23. Malhotra R, Chen C, Huilgol S, et al. Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma. Ophthalmol 2003 110 : 2011 8.
24. Robinson JK. Margin control for lentigo maligna. J Am Acad Dermatol 1994 31 : 79 85.
25. Johnson T, Headington J, Baker S, Lowe L. Usefulness of the staged excision for lentigo maligna and lentigo maligna melanoma: the square procedure. Dermatol Surg 1997 37 : 758 64.
26. Hill DC, Gramp AA. Surgical treatment of lentigo maligna and lentigo maligna melanoma. Aust J Dermatol 1999 40 : 25 30.
27. Huilgol S, Selva D, Chen C, et al. Surgical margins for lentigo maligna and lentigo maligna melanoma. The technique of mapped serial excision. Arch Dermatol 2004 140 : 1087 92.
28. Kimyai-Asadi A, Katz T, Goldberg L, et al. Margin involvement after the excision of melanoma in situ: the need for complete en face examination of the surgical margins. Dermatol Surg 2007 33 : 1434 41.
29. Cohen LM, McCall MW, Hodge SJ, et al. Successful treatment of lentigo maligna and lentigo maligna melanoma with Mohs' micrographic surgery aided by rush permanent sections. Cancer 1994 73 : 2964 70.
30. Temple CLF, Arlette JP. Mohs micrographic surgery in the treatment of lentigo maligna and melanoma. J Surg Oncol 2006 94 : 287 92.
31. Zitelli J, Moy R, Abell E. The reliability of frozen sections in the evaluation of surgical margins for melanoma. Dermatol Surg 1991 24 : 102 6.
32. Barlow RJ, White CR, Swanson NA. Mohs' micrographic surgery using frozen sections alone may be unsuitable for detecting single atypical melanocytes at the margins of melanoma in situ. Br J Dermatol 2002 146 : 290 4.
33. Prieto V, Argenyi Z, Barnhill R, et al. Are en face frozen sections accurate for diagnosing margin status in melanocytic lesions? Am J Clin Pathol 2003 120 : 203 8.
34. Florell SR, Boucher KM, Leachman SA, et al. Histopathologic recognition of involved margins of lentigo maligna excised by staged excision. Arch Dermatol 2003 139 : 595 604.